Search | Invivogen

Human BCMA x E. coli β-Gal Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Evaluation of T cell activation

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-hBCMA-βgal

Recombinant Human CTLA-4-Fc Fusion Protein

Soluble human CTLA-4 (CD152) fused to an IgG1 Fc domain

hCTLA4-Fc analysis by SDS-PAGE

Cell surface staining using hCTLA4-Fc

ELISA detection of hCTLA4-Fc

Activation blockade of Jurkat-Lucia™ TCR-hPD-1 cells

Recombinant Human PD1-Fc Fusion Protein

Soluble human PD-1 (CD279) fused to an IgG1 Fc domain

hPD1-Fc analysis by SDS-PAGE

Cell surface staining using hPD1-Fc

ELISA detection of hPD1-Fc

Recombinant Human ICOS-L-Fc Fusion Protein

Soluble human ICOS-L (CD275) fused to an IgG1 Fc domain

hICOS-L-Fc analysis by SDS-PAGE

Cell surface staining using hICOS-L-Fc

ELISA detection of hICOS-L-Fc

Activation of Jurkat-Lucia™-hICOS cells

Recombinant Human ICOS-Fc Fusion Protein

Soluble human ICOS (CD278) fused to an IgG1 Fc domain

hICOS-Fc analysis by SDS-PAGE

Cell surface staining using hICOS-Fc

ELISA detection of hICOS-Fc

Human EpCAM x E. coli β-Gal Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-hEpCAM-βgal

Human EpCAM x Human CD3 Bispecific Antibody

Solitomab scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Human IL-6R (CD126) Antibody - Tocilizumab IgG1NQ Isotype

Human IgG1 Fc silent

Inhibition of IL-6R signaling by Anti-hIL6R-To-hIgG1NQ

Human IL-6R (CD126) Antibody - Tocilizumab Biosimilar

Human IgG1 - CAS#375823-41-9

Neutralization of cellular response to IL-6 using tocilizumab biosimilar

Human TLR9 Reporter HEK 293 Cells

NF-κB-SEAP reporter cells

Response of HEK-Blue™-derived cells to TLR9 agonists

Dose-response of HEK-Blue™ hTLR9 cells to TLR9 agonists

Response of HEK-Blue™ hTLR9 cells to various PRR agonists and cytokines

NF-κB responses of HEK-Blue™ hTLR9 vs. HEK-Dual™ hTLR9

Human IL-4Rα (CD124) Antibody - Dupilumab IgG1 Isotype

Human IgG1

Neutralization of cellular response to IL-4 and IL-13 using Anti-hIL-4R-hIgG1

Mouse CD3 Antibody (clone 145-2C11)

Mouse IgG2a - For in vivo use

Validation of Anti-mCD3-mIgG2a InvivoFit™ by ELISA

Validation of Anti-mCD3-mIgG2a InvivoFit™ by FACS

Mouse CD8 Antibody (clone YTS 169.4)

Mouse IgG2a - For in vivo use

Validation of Anti-mCD8-mIgG2a binding by FACS

Validation of in vivo CD8 + T cell depletion using Anti-mCD8-mIgG2a InvivoFit™

Mouse CD4 Antibody (clone GK1.5)

Mouse IgG2a - For in vivo use

Validation of Anti-mCD4-mIgG2a binding by FACS

Validation of in vivo CD4 + T cell depletion using Anti-mCD4-mIgG2a InvivoFit™

CR3018-derived Anti SARS-CoV-2 Nucleocapsid hIgG1 antibody

Anti SARS-CoV & SARS-CoV-2 nucleocapsid antibody

Binding of Anti-CoV-N-hIgG1 to SARS-CoV-2 nucelocapsid by ELISA

B38-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes

Anti-SARS-CoV-2-Spike RBD antibody (Clone B38)

Validation of Anti-CoV2RBD-c2-hIgG1 binding to SARS-CoV-2 RBD by ELISA

Neutralization ability of Anti-SARS-CoV-2 Spike-RBD mAbs

Anti-CoV2RBD-c2-mIgG2a ELISA

H4-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes

Anti SARS-CoV-2 Spike RBD antibody

Validation of binding to SARS-CoV-2 RBD by ELISA

Validation of binding to SARS-CoV-2 spike-expressing cells

Neutralization ability of Anti-SARS-CoV-2 Spike-RBD mAbs

Anti-CoV2RBD-c1-mIgG2a ELISA

IFN-α/β Reporter HEK 293 Cells

ISGF3-SEAP reporter cells

Dose-response of HEK-Blue™ IFN-α/β cells to recombinant type I IFNs

Response of HEK-Blue™ IFN-α/β cells to a panel of cytokines

Dose-dependent inhibition of IFN-α signaling in HEK-Blue™ IFN-α/β cells using Rontalizumab or Anifrolumab biosimilars

Dose-dependent inhibition of IFN-β signaling in HEK-Blue™ IFN-α/β cells using Anifrolumab biosimilar

IFN-γ Reporter HEK 293 Cells

STAT1-SEAP reporter cells

Cellular response to human and mouse IFN-γ

Response of HEK-Blue™ IFN-γ cells to a panel of cytokines

Neutralization of IFN-γ signaling using Fontolizumab biosimilar

Human IL-1 Reporter HEK 293 Cells

NF-κB-SEAP reporter cells

Response of HEK-Blue™ IL-1β cells to recombinant IL-1β

Response of HEK-Blue™ IL-1β cells to recombinant IL-1α

HEK-Blue™ IL-1β specificity

Neutralization of hIL-1β signaling using Nidanilimab